ARK Analysis: OpenAI Growth Inflecting Ahead of IPO

DMaguireARK · x · 2026-08-25

ARK's investment newsletter highlights that OpenAI's growth trajectory may be hitting an inflection point ahead of its potential IPO. The report analyzes OpenAI's momentum alongside developments in personalized cancer vaccines by Moderna and Merck, and the scaling of drone delivery in the US.

Original post →

More from Companies & People

Companies & People channel →